In a panel of four mTOR pathway makers (mTOR, p-mTOR, p-AKT, and p-P70S6K) that we evaluated in patients with breast cancer, p-mTOR has the strongest association in relation to body fatness [14]. Here, RPS6KB1 is linked to breast cancer.